Navigation Links
USARAD Including its SecondOpinions.com Division, Launches a Screening Program to Provide Medical Expertise During the Current COVID-19 Pandemic
Date:3/11/2020

USARAD Holdings Inc., the leading US Joint Commission Accredited teleradiology and telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces a first of its kind COVID-19 screening program. The virus has already infected over 100,000 people in over 100 countries and has caused over 4,000 fatalities to date. Over the years, USARAD through its SecondOpinions.com division has provided multi-specialty consultations to patients in over 100 countries for innumerable medical conditions and is ready to assist during the current global health crisis.

Early detection of Coronavirus is essential due to the lack of a known treatment or vaccine. Research by several leading academic radiology departments in USA and China has recently been conducted demonstrating the important role of CT diagnostics. For example, in a study conducted by Mount Sinai Health System and published in the industry-leading journal Radiology, a chest CT scan has significantly outperformed laboratory testing in diagnosing COVID-19 at 98% accuracy vs. 71% results using gene sequencing concluding that CT may be used as the primary screening tool for COVID-19.

USARAD introduces a program where a network of Chest CT-trained Radiologists provides screening diagnostics and consultations alongside other medical specialists including pulmonologists and infectious disease experts. The program is launched in partnership with Medical Diagnostic Web (MDW.io) team operating a blockchain-powered radiologist marketplace which connects hundreds of radiologists readily available to provide radiological diagnosis. The initiative will be utilizing AI algorithms as decision assistive mechanism for the team of radiologists as imaging quantities mount.

Research confirms that certain patterns of atypical pneumonia is seen on CT in patients affected with COVID-19, including ground-glass opacities, peripheral areas of consolidations, “crazy paving” as well as absence of certain findings. The evolution of such findings is critical in understanding the timeline of the disease as well as predicting progression and course of the infection. Radiology specialists are available around the clock to help diagnose or exclude COVID-19. The images can be uploaded via intuitive online service available around the clock. The team of multiple other specialists and subspecialists is also available on stand-by.

Planning for long-term preventive measures, USARAD has partnered with its Israeli Nanox Imaging (http://www.nanox.vision) that has developed a novel medical imaging system based on a digital X-ray source providing highly mobile, small footprint medical screening systems at a fraction of the cost of the industry-standard scanners. The partnership collaborates with global government health authorities planning potential global deployment of thousands of scanners at ports, border waypoints and community medical centers that may enable efficient and timely preventive screening for future outbreaks of COVID-19 or other similar pandemics.

USARAD and Nanox recently announced a joint distribution deal for the deployment of 3,000 Nanox.ARC scanners in the US. Once cleared by the FDA, the Nanox scanners will be dispatched into the high risk areas to provide immediately screening capabilities. Imaging devices can significantly limit patient transportation, facilitate disinfection and therefore lower the risk of virus transmission.

Dr. Michael Yuz, Founder & CEO of USARAD stated: “USARAD together with its strategic partners, MDW and Nanox is available to help patients world-wide during the current COVID-19 pandemic by leveraging the latest science and technology. We are doing everything possible to reduce panic, bringing the peace of mind to millions of patients world-wide.”

About USARAD Holding Inc. including SecondOpinions.com®
USARAD Holdings, Inc. is a global telemedicine company consisting of two operating divisions – USARAD and SecondOpinions.com®. USARAD is a radiology services provider offering interpretations of a full range of sub-specialty and general radiology patient studies. With an existing advanced technology network connecting medical facilities to board-certified radiologists and support staff, USARAD offers radiology services in all 50 states as well as more than 15 countries. Via its unique Radiology-On-Demand® platform, USARAD is committed to providing timely and responsive image review 24/7. SecondOpinions.com® is a medical consultation and second opinions leader providing health care customers, physicians and consumers with expert opinions from all medical specialties and sub-specialties. For more information please visit http://usarad.com & http://secondopinions.com.

About MDW.io
Medical diagnostic web (MDW.io) is first of its kind decentralized autonomous organization operating Blockchain based platform which utilizes smart-contract to facilitate complex B2B and consumer transactions between various stakeholders in radiology field. MDW.io designed to facilitate remote medical diagnostic consultations including radiologic and multispecialty second opinions, peer reviews, primary and preliminary teleradiology interpretations as well as synchronous and asynchronous telemedicine visits. MDW puts patients in forefront of their diagnostic health records by allowing patients and their diagnostic providers to upload findings in a secure, anonymized manner to be further evaluated by the community. For more information please visit http://mdw.io.

About Nanox:
Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies, to provide affordable, early detection imaging service for all. For more information, please visit http://www.nanox.vision.

Read the full story at https://www.prweb.com/releases/usarad_including_its_secondopinions_com_division_launches_a_screening_program_to_provide_medical_expertise_during_the_current_covid_19_pandemic/prweb16973999.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Geosphere features top geoscience technology, including LiDAR, EarthScope, CHIRP, ALSM, and IODP
2. Study helps managers identify regions with multiple threat potential, including wildfires
3. Does including parasites upset food web theory? Yes and no, says new paper
4. Its all in the genes -- including the tracking device
5. Including women on convening committees increases women speakers at scientific meetings
6. Frozen meal eaters get more vegetables including greens, beans and whole grains but with lower total calories vs. fast food restaurant eaters
7. Researchers develop models to study polyelectrolytes, including DNA and RNA
8. PPM Services and Ethical eAdjudication to Implement Clinical Data Management Including IVRS, EDC and Endpoint Adjudication Quality Control in a Phase II Study on Acne
9. ISO9001:2015 Accreditation achieved by Microbiology International for ready-to-use microbiology media, including MediaBox™.
10. Modality Solutions Announces 2019 Year-End Milestones Including ISO 9001:2015, Inc. 5000, Entrepreneur 360™ and More
11. Covetrus North America Now Offers Unique In-Clinic Regenerative Medicine Devices by Enso Discoveries, LLC Including Rebound PRP™ and Rebound PRF®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2020)... Calif. (PRWEB) , ... July 21, 2020 , ... ... driving digital transformation and innovation in technology and compliance, announces a new solution ... device companies must ensure every layer of their technology stack complies with FDA ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • ... comparability study, but what is the most effective way to complete one? Will ...
(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD ... 2022. The network is a consortium of academic research centers in the United ...
(Date:8/3/2020)... Ky. (PRWEB) , ... August 03, 2020 , ... Introducing ... products for transformative growth, , Known as MediVet Biologics since ... brand. , The new Ardent Animal Health will build on its base ...
(Date:7/31/2020)... Mass. and SOMERSET, N.J (PRWEB) , ... July ... ... leading genome editing company, and Catalent, the leading global provider of advanced delivery ... consumer health products, today announced that they have entered into a strategic partnership ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... After research ... The completion of a great surgery is only the beginning of a successful study, ... research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
Breaking Biology Technology: